Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females.

Lee TY, Yu CC, Wu CC, Chang CS, Lin JT, Wu MS, Chen HP, Wu CY.

Hepatogastroenterology. 2013 Feb 1;60(126). doi: 10.5754/hge12993. [Epub ahead of print]

PMID:
23372116
2.

Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.

Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J.

Breast Cancer Res Treat. 2006 Jan;95(1):65-72. Epub 2005 Nov 3.

PMID:
16267613
3.

Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.

Wu CY, Wu MS, Chen YJ, Chen CJ, Chen HP, Shun CT, Chen GH, Huang SP, Lin JT.

Eur J Cancer. 2007 Mar;43(4):799-808. Epub 2007 Jan 22.

PMID:
17236757
4.

Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.

Tang Y, Zhu J, Chen L, Chen L, Zhang S, Lin J.

Clin Cancer Res. 2008 May 1;14(9):2870-7. doi: 10.1158/1078-0432.CCR-07-4042.

5.

Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.

Wu CY, Wu MS, Chen YJ, Chen HP, Chen CJ, Chang CS, Lin JT.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1890-4.

PMID:
19102416
7.

A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.

Matsumura S, Oue N, Kitadai Y, Chayama K, Yoshida K, Yamaguchi Y, Toge T, Imai K, Nakachi K, Yasui W.

J Cancer Res Clin Oncol. 2004 May;130(5):259-65. Epub 2004 Feb 18.

PMID:
14986114
8.

A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer.

Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K, Yasui W.

J Cancer Res Clin Oncol. 2005 Jan;131(1):19-25. Epub 2004 Sep 30.

PMID:
15565457
9.

[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].

Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.

Ai Zheng. 2005 Mar;24(3):305-10. Chinese.

PMID:
15757531
10.

[Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].

Zhang XM, Miao XP, Xiong P, Yu CY, Tan W, Qu SN, Sun T, Zhou YF, Lin DX.

Ai Zheng. 2004 Nov;23(11):1233-7. Chinese.

PMID:
15522165
11.

Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.

Lai HC, Chu CM, Lin YW, Chang CC, Nieh S, Yu MH, Chu TY.

Gynecol Oncol. 2005 Feb;96(2):314-9.

PMID:
15661214
12.
13.

[Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].

Lin XD, Chen G, Li C, Zhang LY, Shi Y, Zhou DM, Zheng XW.

Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Aug;45(8):711-6. Chinese.

PMID:
22169692
14.

Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.

Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.

PMID:
9356878
15.

A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.

Xu E, Lai M, Lv B, Xing X, Huang Q, Xia X.

Biochem Biophys Res Commun. 2004 Nov 19;324(3):999-1003.

PMID:
15485653
16.

Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.

Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6673-80.

17.

Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer.

Tsuchiya N, Narita S, Kumazawa T, Inoue T, Ma Z, Tsuruta H, Saito M, Horikawa Y, Yuasa T, Satoh S, Ogawa O, Habuchi T.

Oncol Rep. 2009 Sep;22(3):493-9.

PMID:
19639194
18.

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9.

19.

Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese.

Xu E, Xia X, Lü B, Xing X, Huang Q, Ma Y, Wang W, Lai M.

Mol Carcinog. 2007 Nov;46(11):924-9.

PMID:
17546628
20.

Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.

Pereza N, Ostojić S, Volk M, Kapović M, Peterlin B.

Reprod Biomed Online. 2012 May;24(5):567-75. doi: 10.1016/j.rbmo.2012.01.008. Epub 2012 Jan 24.

PMID:
22406112

Supplemental Content

Support Center